182 related articles for article (PubMed ID: 23625955)
1. The influence of gender on the development of pulmonary arterial hypertension.
Dempsie Y; MacLean MR
Exp Physiol; 2013 Aug; 98(8):1257-61. PubMed ID: 23625955
[TBL] [Abstract][Full Text] [Related]
2. Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension.
Dempsie Y; MacRitchie NA; White K; Morecroft I; Wright AF; Nilsen M; Loughlin L; Mair KM; MacLean MR
Cardiovasc Res; 2013 Jul; 99(1):24-34. PubMed ID: 23519266
[TBL] [Abstract][Full Text] [Related]
3. Progress in solving the sex hormone paradox in pulmonary hypertension.
Lahm T; Tuder RM; Petrache I
Am J Physiol Lung Cell Mol Physiol; 2014 Jul; 307(1):L7-26. PubMed ID: 24816487
[TBL] [Abstract][Full Text] [Related]
4. The Role of Sex in the Pathophysiology of Pulmonary Hypertension.
Docherty CK; Harvey KY; Mair KM; Griffin S; Denver N; MacLean MR
Adv Exp Med Biol; 2018; 1065():511-528. PubMed ID: 30051404
[TBL] [Abstract][Full Text] [Related]
5. Development of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease.
Pugh ME; Hemnes AR
Womens Health (Lond); 2010 Mar; 6(2):285-96. PubMed ID: 20187732
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Arterial Hypertension and the Sex Hormone Paradox.
Foderaro A; Ventetuolo CE
Curr Hypertens Rep; 2016 Nov; 18(11):84. PubMed ID: 27832457
[TBL] [Abstract][Full Text] [Related]
7. Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.
Hester J; Ventetuolo C; Lahm T
Compr Physiol; 2019 Dec; 10(1):125-170. PubMed ID: 31853950
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension in women.
Pugh ME; Hemnes AR
Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1549-58. PubMed ID: 21090930
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
[TBL] [Abstract][Full Text] [Related]
10. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
Yang JM; Zhou R; Zhang M; Tan HR; Yu JQ
Molecules; 2018 May; 23(6):. PubMed ID: 29861433
[TBL] [Abstract][Full Text] [Related]
11. The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension.
White K; Dempsie Y; Nilsen M; Wright AF; Loughlin L; MacLean MR
Cardiovasc Res; 2011 May; 90(2):373-82. PubMed ID: 21177701
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in the pulmonary circulation: implications for pulmonary hypertension.
Martin YN; Pabelick CM
Am J Physiol Heart Circ Physiol; 2014 May; 306(9):H1253-64. PubMed ID: 24610923
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response.
Mair KM; Johansen AK; Wright AF; Wallace E; MacLean MR
Br J Pharmacol; 2014 Feb; 171(3):567-79. PubMed ID: 23802760
[TBL] [Abstract][Full Text] [Related]
14. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
[TBL] [Abstract][Full Text] [Related]
15. Sex and gender in pulmonary arterial hypertension.
Cheron C; McBride SA; Antigny F; Girerd B; Chouchana M; Chaumais MC; Jaïs X; Bertoletti L; Sitbon O; Weatherald J; Humbert M; Montani D
Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34750113
[TBL] [Abstract][Full Text] [Related]
16. A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil.
Bombicz M; Priksz D; Varga B; Kurucz A; Kertész A; Takacs A; Posa A; Kiss R; Szilvassy Z; Juhasz B
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28677661
[TBL] [Abstract][Full Text] [Related]
17. The metabolic theory of pulmonary arterial hypertension.
Paulin R; Michelakis ED
Circ Res; 2014 Jun; 115(1):148-64. PubMed ID: 24951764
[TBL] [Abstract][Full Text] [Related]
18. Connexin-mediated regulation of the pulmonary vasculature.
Dempsie Y; Martin P; Upton PD
Biochem Soc Trans; 2015 Jun; 43(3):524-9. PubMed ID: 26009202
[TBL] [Abstract][Full Text] [Related]
19. Definition, classification, and epidemiology of pulmonary arterial hypertension.
Hoeper MM
Semin Respir Crit Care Med; 2009 Aug; 30(4):369-75. PubMed ID: 19634076
[TBL] [Abstract][Full Text] [Related]
20. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
